Morflora’s IP includes extensive know how in gene expression and silencing technologies, mounted up through years of research. Morflora holds proprietary IP composed of several families of patents at different stages of approval and registration. The patent portfolio includes several patents in trait delivery protocols, methods and machinery. In addition there are several patents under joint-ownership and exclusive licensing agreement with Yissum (the Research Development Company of the Hebrew University of Jerusalem), encompassing the TraitUP™ platform and Seed treatment. The IP and the accumulated know how ensure Morflora’s ability to broaden its solution, treatment offerings, and secure its market leadership with several extensive patents.

© All rights reserved to Morflora | Contact | Site Map                                                                  
 Marketing & Branding Strategy by Pearlcom | Designed by Render | Website Development by Itdes